Global Regulatory Intelligence
Log in |  Register

Login to your account

Username *
Password *
Remember Me

Create an account

Registering to our Regulatory Updates easy andis should only
take few minutes. To begin, enter your email enter your email
address below so we can check to see if it is already existing
in our records. Your email address will also be used as your
user name when you log in.

Fields marked with an asterisk (*) are required.
Name *
Username *
Password *
Verify password *
Email *
Verify email *
Captcha *
Reload Captcha

EU: Adjusted Fees for Pharmacovigilance Applications to EMA from January 2018

Wednesday, December 20, 2017: The European Medicines Agency (EMA) reminds applicants and marketing authorisation holders that adjusted fees for pharmacovigilance applications are expected to come into effect in mid-January 2018.

The European Commission adopted a regulation adjusting the pharmacovigilance fees payable to the Agency on 18 October 2017. Following a two-month consultation with the Council and Parliament, the amended regulation is expected to be published in January 2018.

Since pharmacovigilance fees were not adjusted in 2016 to reflect the 2015 inflation rate of 0.2%, this increase is added to the 2016 inflation rate adjustment of 1.2%, resulting in a total increase of 1.4%.

The Agency will publish full details of the revised fees in January 2018, once the consultation period ends, and the amended regulation is published in the Official Journal of the European Union.

More Details
© 2016 MakroCare. All Rights Reserved.
  Privacy policy